CeQur secures $100 million in Series C funding - MarketLine Financial Deals

CeQur secures $100 million in Series C funding

CeQur secures $100 million in Series C funding - MarketLine Financial Deals
CeQur secures $100 million in Series C funding
Published Sep 01, 2015
4 pages — Published Sep 01, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CeQur SA, a Switzerland-based developer of drug delivery devices for diabetes patients, has secured $100 million in Series C funding round.

  
Source:
Document ID
MA158881_150902
Country
Country
Ticker
SDR=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CeQur secures $100 million in Series C funding" Sep 01, 2015. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CeQur-secures-100-million-in-Series-C-funding-2052-112528>
  
APA:
MarketLine Financial Deals. (2015). CeQur secures $100 million in Series C funding Sep 01, 2015. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CeQur-secures-100-million-in-Series-C-funding-2052-112528>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.